Tazarotene-Induced Gene 3 Is Suppressed in Basal Cell Carcinomas and Reversed In Vivo by Tazarotene Application
- 1 October 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 121 (4), 902-909
- https://doi.org/10.1046/j.1523-1747.2003.12488.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Gene expression regulation by retinoic acidJournal of Lipid Research, 2002
- The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity.International Journal of Oncology, 2000
- Cytokine expression patterns distinguish HIV associated skin diseasesExperimental Dermatology, 2000
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999
- Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined regionOncogene, 1999
- Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory geneProceedings of the National Academy of Sciences, 1998
- Molecular mechanisms of tazarotene action in psoriasisJournal of the American Academy of Dermatology, 1997
- Sunlight and skin cancer: Inhibition of p53 mutations in UV-irradiated mouse skin by sunscreensNature Medicine, 1997
- The Molecular and Genetic Dissection of the Retinoid Signaling PathwayPublished by Elsevier ,1995
- Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements.Molecular and Cellular Biology, 1992